7min chapter

The HemOnc Pulse cover image

Krish Patel, MD, Talks Glofitamab, Other Novel Therapies in DLBCL

The HemOnc Pulse

CHAPTER

Exploring Bi-Specific Antibodies in Lymphoma Treatment

Discussion on the challenges of selecting the most suitable bi-specific antibody for lymphoma treatment, considering dosing intervals, therapy durations, patient preferences, and therapy sequencing. Emphasis on shared decision-making, therapy delivery considerations, future prospects, and emerging risks in utilizing bi-specific antibodies.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode